RGBP·July 15, 2026·litigation
Regen BioPharma Settles Creditor Claim With Court-Approved Stock Issuance and Replaces Auditor
Regen BioPharma reached a court-approved settlement to resolve a $398,740 claim by issuing shares of its stock, and it replaced its independent auditor after that firm’s attest business was acquired.